Latest papers

Obesity genes and insulin resistance.

Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?

Association between four adipokines and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population.

Cloning, expression analysis, and regulatory mechanisms of bovine chemerin and chemerin receptor

Regulation of adipokine secretion by n-3 fatty acids.

Molecular aspects of adipokine-bone interactions.

Effect of obesity on growth-related oncogene factor-alpha, thrombopoietin, and tissue inhibitor metalloproteinase-1 serum levels.

[Adipocytokines and assay method in metabolic syndrome].

ER stress in adipocytes inhibits insulin signaling, represses lipolysis, and alters the secretion of adipokines without inhibiting glucose transport.

Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.

Cloning of porcine chemerin, ChemR23 and GPR1 and their involvement in regulation of lipogenesis.

Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells.

Adipocytokines and blood pressure, lipids and glucose metabolism in hypertensive perimenopausal women.

Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity.

Cystatin C, adipokines and cardiovascular risk in HIV infected patients.

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery.

Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome.

Adipose tissue in renal disease: clinical significance and prognostic implications.

Targeted label-free quantitative analysis of secretory proteins from adipocytes in response to oxidative stress

Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: The two sides of the same coin